• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microvasc Res . Evaluation of retinal and optic disc vascular structures in individuals before and after Pfizer-BioNTech vaccination

tetano

Editor, Senior Moderator
Microvasc Res


. 2023 Feb 4;104500.
doi: 10.1016/j.mvr.2023.104500. Online ahead of print.
Evaluation of retinal and optic disc vascular structures in individuals before and after Pfizer-BioNTech vaccination


Birumut Gedik[SUP] 1 [/SUP], Muhammet Kazim Erol[SUP] 2 [/SUP], Elcin Suren[SUP] 2 [/SUP], Sibel Yavuz[SUP] 2 [/SUP], Mehmet Fatih Kucuk[SUP] 2 [/SUP], Yigit Caglar Bozdogan[SUP] 2 [/SUP], Rojbin Ekinci[SUP] 2 [/SUP], Melih Akidan[SUP] 3 [/SUP]



Affiliations

Abstract

Introduction: We conducted this study to detect possible changes in posterior segment structures using the optical coherence tomography angiography (OCTA) in individuals vaccinated with the Pfizer-BioNTech vaccine.
Materials and methods: The study included healthcare professionals who presented to the Ophthalmology Clinic of Health Sciences University Antalya Training and Research Hospital, who were scheduled to receive the first dose of the Pfizer-BioNTech vaccine. The exclusion criteria were any eye pathology (e.g., glaucoma, uveitis, diabetic retinopathy, amblyopia), myopia with the absolute value of refractive error >6, axial length >26 mm, history of eye surgery, and presence of systemic disease.OCTA was performed to 40 healthcare professionals before vaccination and on the third day after vaccination.
Results: After Pfizer-BioNTech vaccination, there was a statistically significant decrease in the total vascular, foveal vascular, parafoveal vascular and perifoveal vascular density of the superficial capillary plexus and the perifoveal vascular density of the deep capillary plexus and a statistically significant increase in the retinal foveal thickness and total retinal parafoveal thickness compared to the pre-vaccination values (p < 0.0001, p = 0.009, p < 0.0001, p = 0.001, p = 0.04, p = 0.03, and p = 0.05, respectively).
Conclusion: We consider that the decrease in the retinal vascular density may be due to vascular endothelial damage and inflammation in vaccinated people. It can be suggested that increased inflammation plays a role in the retinal thickness in vaccinated people similar to patients with a history of COVID-19. We also consider that spike protein may be effective in these processes.

Keywords: COVID-19; Coronavirus; Optic coherence tomography angiography; Pfizer-BioNTech; Spike protein.
 
Back
Top Bottom